COPD News

Dupilumab led to improvement and was safe in adults with moderate to severe COPD and type 2 inflammation at week 52, according to a pooled analysis of BOREAS and NOTUS presented at the European Respiratory Society International Congress.

Patients with severe emphysema had lasting lung function improvement 5 years after bronchoscopic lung volume reduction with Zephyr Valves, according to a poster presented at the European Respiratory Society International Congress.

Healio has compiled the most-read news in pulmonology posted in August.

The University of California, Davis Health has established a population health-based action plan to help health systems and care teams stay on top of wildfires and protect patients with COPD and asthma, according to a press release.

In the first half of 2024, many posts on X, formerly Twitter, from U.S. health care professionals discussing COPD treatments focused on beta-blockers, dupilumab and ensifentrine, according to a tracker from Creation Healthcare.

Inhaler misuse was high in hospitalized patients with COPD, with 69.4% of all inhalers at admission found to be misused, according to results published in Chronic Obstructive Pulmonary Diseases: Journal of the COPD Foundation.

It has been previously found that reduced levels of moderate to vigorous intensity physical activity are linked to increased symptom burden in patients with COPD, stressing the importance of exercise.

A small proportion of adults with COPD used pulmonary rehabilitation in 2013, and this did not change much in 2019, according to results published in Annals of the American Thoracic Society.

Factors linked to better inhaled COPD medication adherence in veterans included older age, a higher number of maintenance inhalers used and chronic prednisone use, according to results published in Annals of the American Thoracic Society.

Four variables, including chronic bronchitis and high symptom burden, heightened the rate of exacerbations among patients with COPD and no recent exacerbations, according to results published in Annals of the American Thoracic Society.